E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/25/2016 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $3.08 million phoenix autocallables tied to three funds

By Wendy Van Sickle

Columbus, Ohio, Oct. 25 – Barclays Bank plc priced $3.08 million of phoenix autocallable notes due Oct. 25, 2018 linked to the least performing of the iShares Nasdaq Biotechnology exchange-traded fund, the Financial Select Sector SPDR fund and the Technology Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 14.68% if each fund closes at or above its barrier level, 75% of its initial level, on the observation date for that quarter.

The notes will be called at par plus the contingent coupon if each fund closes at or above its initial level on any observation date other than the final date.

The payout at maturity will be par plus the contingent coupon unless any fund finishes below its barrier level, in which case investors will be fully exposed to any losses of the worst performing fund.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Phoenix autocallable notes
Underlying funds:iShares Nasdaq Biotechnology exchange-traded fund, Financial Select Sector SPDR fund, Technology Select Sector SPDR fund
Amount:$3,083,000
Maturity:Oct. 25, 2018
Coupon:14.68% per year, payable quarterly if each fund closes at or above barrier level on observation date for that quarter
Price:Par
Payout at maturity:Par plus the contingent coupon unless any fund finishes below its barrier level, in which case investors will be fully exposed to any losses of the least performing fund
Call:At par plus the contingent coupon if each fund closes at or above its initial level on any observation date other than final date
Initial prices:$267.77 for biotech fund, $19.65 for financial sector fund, $47.53 for technology sector fund
Barrier level:$200.83 for biotech fund, $14.74 for financial sector fund, $35.65 for technology sector fund, 75% of initial price
Pricing date:Oct. 21
Settlement date:Oct. 26
Agent:Barclays
Fees:1.75%
Cusip:06741VDF6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.